Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michèle Reboud-Ravaux

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
European Journal of Medicinal Chemistry|January 18, 2018
Structure-based design of human immuno- and constitutive proteasomes inhibitorsNicolas Richy, Daad Sarraf, Xavier Maréchal, et al.
Oncotarget|January 7, 2017
Blockade of the malignant phenotype by β-subunit selective noncovalent inhibition of immuno- and constitutive proteasomesBruno O Villoutreix, Abdel-Majid Khatib, Yan Cheng, et al.
Chemmedchem|October 12, 2010
Toward the first nonpeptidic molecular tong inhibitor of wild-type and mutated HIV-1 protease dimerizationAnamaria Vidu, Laure Dufau, Ludovic Bannwarth, et al.
Biochimie|November 21, 2007
Towards the control of intracellular protein turnover: mitochondrial Lon protease inhibitors versus proteasome inhibitorsAurélien Bayot, Nicolas Basse, Irene Lee, et al.
Journal of Medicinal Chemistry|May 7, 2020
Structural Studies on the Inhibitory Binding Mode of Aromatic Coumarinic Esters to Human Kallikrein-Related Peptidase 7Stefanie Hanke, Catherine A Tindall, Jan Pippel, et al.
Journal of Medicinal Chemistry|July 21, 2006
Molecular tongs containing amino acid mimetic fragments: new inhibitors of wild-type and mutated HIV-1 protease dimerizationLudovic Bannwarth, Albane Kessler, Stéphanie Pèthe, et al.
Journal of Medicinal Chemistry|April 2, 2013
Dimerized linear mimics of a natural cyclopeptide (TMC-95A) are potent noncovalent inhibitors of the eukaryotic 20S proteasomeAudrey Desvergne, Emilie Genin, Xavier Maréchal, et al.
Biological Chemistry|April 12, 2018
Insights into the activity control of the kallikrein-related peptidase 6: small-molecule modulators and allosterismFeryel Soualmia, Elodie Bosc, Sabrina Aït Amiri, et al.
Bioorganic & Medicinal Chemistry Letters|December 2, 2008
Novel fluorinated pseudopeptides as proteasome inhibitorsLucia Formicola, Xavier Maréchal, Nicolas Basse, et al.
European Journal of Medicinal Chemistry|November 12, 2013
Identification by in silico and in vitro screenings of small organic molecules acting as reversible inhibitors of kallikreinsXiao Tan, Claudia Bertonati, Lixian Qin, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
European Journal of Medicinal Chemistry|January 18, 2018
Structure-based design of human immuno- and constitutive proteasomes inhibitorsNicolas Richy, Daad Sarraf, Xavier Maréchal, et al.
Oncotarget|January 7, 2017
Blockade of the malignant phenotype by β-subunit selective noncovalent inhibition of immuno- and constitutive proteasomesBruno O Villoutreix, Abdel-Majid Khatib, Yan Cheng, et al.
Chemmedchem|October 12, 2010
Toward the first nonpeptidic molecular tong inhibitor of wild-type and mutated HIV-1 protease dimerizationAnamaria Vidu, Laure Dufau, Ludovic Bannwarth, et al.
Biochimie|November 21, 2007
Towards the control of intracellular protein turnover: mitochondrial Lon protease inhibitors versus proteasome inhibitorsAurélien Bayot, Nicolas Basse, Irene Lee, et al.
Journal of Medicinal Chemistry|May 7, 2020
Structural Studies on the Inhibitory Binding Mode of Aromatic Coumarinic Esters to Human Kallikrein-Related Peptidase 7Stefanie Hanke, Catherine A Tindall, Jan Pippel, et al.
Journal of Medicinal Chemistry|July 21, 2006
Molecular tongs containing amino acid mimetic fragments: new inhibitors of wild-type and mutated HIV-1 protease dimerizationLudovic Bannwarth, Albane Kessler, Stéphanie Pèthe, et al.
Journal of Medicinal Chemistry|April 2, 2013
Dimerized linear mimics of a natural cyclopeptide (TMC-95A) are potent noncovalent inhibitors of the eukaryotic 20S proteasomeAudrey Desvergne, Emilie Genin, Xavier Maréchal, et al.
Biological Chemistry|April 12, 2018
Insights into the activity control of the kallikrein-related peptidase 6: small-molecule modulators and allosterismFeryel Soualmia, Elodie Bosc, Sabrina Aït Amiri, et al.
Bioorganic & Medicinal Chemistry Letters|December 2, 2008
Novel fluorinated pseudopeptides as proteasome inhibitorsLucia Formicola, Xavier Maréchal, Nicolas Basse, et al.
European Journal of Medicinal Chemistry|November 12, 2013
Identification by in silico and in vitro screenings of small organic molecules acting as reversible inhibitors of kallikreinsXiao Tan, Claudia Bertonati, Lixian Qin, et al.
Pageof 5